Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership1,754,619 shares
Ownership 4.69%
Fmr Llc ownership in PCRX / Pacira BioSciences, Inc.

2017-01-10 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,754,619 shares of Pacira BioSciences, Inc. (US:PCRX). This represents 4.691 percent ownership of the company. In their previous filing dated 2016-02-12 , Fmr Llc had reported owning 3,925,537 shares, indicating a decrease of -55.30 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2017-01-10 2017-01-10 13G/A 3,925,537 1,754,619 -55.30 4.69 -56.07
2016-02-12 2016-02-12 13G/A 3,840,969 3,925,537 2.20 10.68 1.33
2015-08-10 2015-08-10 13G/A 3,840,969 10.54
2015-02-13 2015-02-13 13G/A 3,190,622 8.85
2014-02-14 2014-02-14 13G/A 3,681,620 10.98
2013-09-10 2013-09-10 13G 3,550,393 10.66

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 93,481 19,585 26.50 2,113 10.46 0.0000
2026-02-17 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 73,896 -27,928 -27.43 1,912 -27.13 0.0001
2025-11-13 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 101,824 9,144 9.87 2,624 18.47 0.0001
2025-08-14 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 92,680 -53,480 -36.59 2,215 -39.01 0.0001
2025-05-12 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 146,160 66,789 84.15 3,632 142.94 0.0002
2025-02-13 2024-12-31 13F PACIRA BIOSCIENCES COM 695127100 79,371 12,206 18.17 1,495 48.02 0.0001
2024-11-13 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 67,165 24,159 56.18 1,011 -17.89 0.0001
2024-08-13 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 43,006 863 2.05 1,230 -0.08 0.0001
2024-05-13 2024-03-31 13F PACIRA BIOSCIENCES COM 695127100 42,143 -12,469 -22.83 1,231 -33.17 0.0001
2024-02-13 2023-12-31 13F PACIRA BIOSCIENCES COM 695127100 54,612 -760 -1.37 1,843 8.48 0.0001
2023-11-13 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 55,372 6,499 13.30 1,699 -13.28 0.0001
2023-08-11 2023-06-30 13F PACIRA BIOSCIENCES COM 695127100 48,873 -961 -1.93 1,958 -3.69 0.0002
2023-08-11 2023-03-31 13F/A-1 PACIRA BIOSCIENCES COM 695127100 49,834 1,699 3.53 2,034 9.42 0.0002
2023-05-11 2023-03-31 13F PACIRA BIOSCIENCES COM 695127100 49,834 1,699 2,034 0.0000
2023-02-13 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 48,135 -1,089 -2.21 1,858 -29.03 0.0002
2022-11-10 2022-09-30 13F PACIRA BIOSCIENCES COM 695127100 49,224 481 0.99 2,618 -7.88 0.0003
2022-08-12 2022-06-30 13F PACIRA BIOSCIENCES COM 695127100 48,743 2,559 5.54 2,842 -19.38 0.0003
2022-05-13 2022-03-31 13F PACIRA BIOSCIENCES COM 695127100 46,184 45,840 13,325.58 3,525 16,685.71 0.0003
2022-02-14 2021-12-31 13F PACIRA BIOSCIENCES COM 695127100 344 278 421.21 21 425.00 0.0000
2022-02-14 2021-09-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 66 4 6.45 4 0.00 0.0000
2021-11-15 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 66 4 4 0.0000
2021-08-13 2021-06-30 13F PACIRA BIOSCIENCES COM 695127100 62 -1 -1.59 4 0.00 0.0000
2021-05-14 2021-03-31 13F PACIRA BIOSCIENCES COM 695127100 63 7 12.50 4 33.33 0.0000
2021-02-08 2020-12-31 13F PACIRA BIOSCIENCES COM 695127100 56 -138,427 -99.96 3 -99.96 0.0000
2020-11-13 2020-09-30 13F PACIRA BIOSCIENCES COM 695127100 138,483 138,427 247,191.07 8,325 277,400.00 0.0008
2020-08-24 2020-06-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 56 56 3 0.0000
2020-08-13 2020-06-30 13F PACIRA BIOSCIENCES COM 695127100 56 56 3 0.0737
2020-05-14 2020-03-31 13F PACIRA BIOSCIENCES COM 695127100 0 -40 -100.00 0 -100.00
2020-02-07 2019-12-31 13F PACIRA BIOSCIENCES COM 695127100 40 40 2 0.0000
2019-02-13 2018-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 0 -125 -100.00 0 -100.00
2018-11-09 2018-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 125 125 6 0.0000
2018-05-14 2018-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 0 -311,919 -100.00 0 -100.00
2018-02-12 2017-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 311,919 -152,800 -32.88 14,239 -18.40 0.0017
2017-11-13 2017-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 464,719 -156,400 -25.18 17,450 -41.10 0.0021
2017-08-29 2017-06-30 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 621,119 -257,600 -29.32 29,627 -26.06 0.0037
2017-08-11 2017-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 621,119 -257,600 29,627
2017-05-11 2017-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 878,719 -875,900 -49.92 40,070 -29.30 0.0051
2017-02-10 2016-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 1,754,619 -2,546,235 -59.20 56,674 -61.49 0.0076
2016-11-14 2016-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 4,300,854 -1,266,234 -22.74 147,175 -21.62 0.0196
2016-08-11 2016-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 5,567,088 892,511 19.09 187,778 -24.18 0.0256
2016-05-16 2016-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 4,674,577 749,040 19.08 247,659 -17.84 0.0343
2016-02-12 2015-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,925,537 938,039 31.40 301,442 145.50 0.0406
2015-11-10 2015-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 2,987,498 -538,408 -15.27 122,786 -50.76 0.0175
2015-08-25 2015-06-30 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 3,525,906 202,073 6.08 249,352 -15.57 0.0320
2015-08-13 2015-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 3,525,906 249,352
2015-05-14 2015-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,323,833 134,611 4.22 295,323 4.44 0.0376
2015-02-17 2014-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,189,222 -1,915 -0.06 282,757 -8.58 0.0368
2014-11-14 2014-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 3,191,137 84,355 2.72 309,285 8.37 0.0419
2014-08-14 2014-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 3,106,782 -30,438 -0.97 285,388 29.97 0.0383
2014-05-15 2014-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,137,220 -544,400 -14.79 219,574 3.74 0.0305
2014-02-13 2013-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,681,620 199,027 5.71 211,657 26.38 0.0299
2013-11-14 2013-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 3,482,593 787,065 29.20 167,477 114.25 0.0257
2013-09-24 2013-06-30 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 2,695,528 2,695,528 78,170 0.0128
2013-08-14 2013-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 2,695,528 78,170 0.0128
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.